Title Here

5,000,000 € D-ORBIT has designed its own technology for the traditional space market, with its high level of reliability and quality and now extends it to the actors of the ‘New Space’ market with two flagship products: ION and D3.

View the company record

Upcoming operation

PEA PEA-PME

LNC Therapeutics

7,000,000 €

LNC Therapeutics is a French company created in 2010 specialized in the discovery of drugs based on the intestinal microbiome. LNC is positioned as the only player capable of providing an effective solution against obesity with drugs and medical-food products derived from the intestinal microbiome that treat the problem at its source.

Closed operation

Crosstalent

3,000,000 €

Crosstalent is a French editor that markets Cloud and SaaS software for HR and talent management.

Closed operation

IR ISF PEA PEA-PME

Medsteer

2,000,000 €

Medsteer develops a device that reduces post-operative disorders by regulating real-time anesthesia during an operation. By relying on the patient's brain activity, the device avoids periods of deep sleep which cause many side effects.

Closed operation

IR PEA PEA-PME

NH TherAguix

1,000,000 €

NH TherAguix is a pharmaceutical company developing innovative nanomedicine that improves the benefits of radiotherapy without modifying current clinical methods. AGuIX® protected by 4 international patents, is currently in phase 1 on the treatment of brain metastases.

Closed operation

PEA PEA-PME IR ISF

Wimi

1,500,000 €

Wimi has the ambition to increase by 20% teamwork productivity. To do so, Wimi offers a digital solution integrating a complete range of services: documents sharing and Drive, tasks management, chat & channels, calendars, video conferences… Wimi is the only solution offering unified workspaces dedicated to teamwork.

Closed operation

PEA PEA-PME IR

AlzProtect

14,000,000 €

AlzProtect is developing AZP2006, a major step forward in the treatment of the Alzheimer's disease, and by extension, in the treatment of neurodegenerative diseases. The product AlzProtect, protected by four families of patents, is entering into the phase 1b.

Closed operation

IR ISF PEA PEA-PME

InnaVirVAx

2,000,000 €

InnaVirVax develops a therapeutic vaccine against HIV, allowing for patients’ functional cure or remission. Phase I/IIa results have showed in 2015 a significant decrease of the “viral reserve”.

Closed operation

PEA PEA-PME

boostHEAT

4,000,000 €

boostHeat has developed a boiler that divides by two energy consumption and environmental footprint, compared to the best current condensing boilers.

Legal notices by vingtcinq

FR | EN